Exero Medical key facts
as of Oct 2026- Developer of a biodegradable wireless sensor designed for early detection of anastomotic leaks following gastrointestinal surgery.
- Exero Medical is valued at approximately $13.0M as of Oct 2026 (last reported valuation).
- It has raised $14.0M; the latest was Later Stage VC ($12.7M) in Feb 2025.
- Notable investors include Innovation Authority, Tech Council Ventures, Consensus Business Group, Intellectual Ventures, ARC Innovation Center — 10 tracked in total.
- Status: Privately Held (backing).
Exero Medical's last reported valuation, Feb 2025. Nothing priced has surfaced since.
- ·Watch Exero Medical: the Monday email on marks, rounds and moves
Exero Medical funding rounds
No funding rounds for Exero Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Exero Medical valuation
Exero Medical's last reported valuation was $13 million in Feb 2025. No priced round, secondary trade or fund mark has surfaced since.
Exero Medical investors
10 investors are on record for Exero Medical, including Innovation Authority, Tech Council Ventures, Consensus Business Group and Intellectual Ventures.
About Exero Medical
Developer of a biodegradable wireless sensor designed for early detection of anastomotic leaks following gastrointestinal surgery. The company's device provides patient recovery, the generation of new real-time data, and shorter hospitalization, enabling medical professionals to monitor the condition of the anastomosis area and take preventive actions before the patient's condition deteriorates.
- Sector
- Healthcare
- HQ
- Or Yehuda, Israel
- Founded
- 2018
- Employees
- 9
- Website
- exeromedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.